59 research outputs found
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
Purpose: In neuroblastoma (NB), the ALK receptor tyrosine kinase can be constitutively activated through activating point mutations or genomic amplification. We studied ALK genetic alterations in high-risk (HR) patients on the HR-NBL1/SIOPEN trial to determine their frequency, correlation with clinical parameters, and prognostic impact.
Materials and methods: Diagnostic tumor samples were available from 1,092 HR-NBL1/SIOPEN patients to determine ALK amplification status (n = 330), ALK mutational profile (n = 191), or both (n = 571).
Results: Genomic ALK amplification (ALKa) was detected in 4.5% of cases (41 out of 901), all except one with MYCN amplification (MNA). ALKa was associated with a significantly poorer overall survival (OS) (5-year OS: ALKa [n = 41] 28% [95% CI, 15 to 42]; no-ALKa [n = 860] 51% [95% CI, 47 to 54], [P 20% mutated allele fraction) in 10% of cases (76 out of 762) and at a subclonal level (mutated allele fraction 0.1%-20%) in 3.9% of patients (30 out of 762), with a strong correlation between the presence of ALKm and MNA (P < .001). Among 571 cases with known ALKa and ALKm status, a statistically significant difference in OS was observed between cases with ALKa or clonal ALKm versus subclonal ALKm or no ALK alterations (5-year OS: ALKa [n = 19], 26% [95% CI, 10 to 47], clonal ALKm [n = 65] 33% [95% CI, 21 to 44], subclonal ALKm (n = 22) 48% [95% CI, 26 to 67], and no alteration [n = 465], 51% [95% CI, 46 to 55], respectively; P = .001). Importantly, in a multivariate model, involvement of more than one metastatic compartment (hazard ratio [HR], 2.87; P < .001), ALKa (HR, 2.38; P = .004), and clonal ALKm (HR, 1.77; P = .001) were independent predictors of poor outcome.
Conclusion: Genetic alterations of ALK (clonal mutations and amplifications) in HR-NB are independent predictors of poorer survival. These data provide a rationale for integration of ALK inhibitors in upfront treatment of HR-NB with ALK alterations.Key Objective: High risk neuroblastoma (HR-NB) is one of the most difficult childhood cancers to cure. This study examined whether the presence of an ALK alteration (amplification or mutation) was associated with a poor prognosis in a large patient series treated on the prospective European high-risk neuroblastoma trial (HR-NBL1).
Knowledge Generated: We found that ALK amplification or clonal mutation was associated with inferior prognosis in patients with HR-NB and both are independent prognostic variables on multivariate analysis. To our knowledge, this is the first study to report the highly prognostic significance of ALK amplification in HR-NB.
Relevance: As ALK can be targeted therapeutically, this study convincingly argues for the introduction of ALK inhibitors for upfront management of patients with HR-NB with ALK aberrations. Importantly, the prognostic significance of ALK alterations included a subgroup of trial patients treated with the current standard of care for HR-NB including anti-GD2 immunotherapy.info:eu-repo/semantics/publishedVersio
Das Scheitern des klassischen Konzepts der vorbeugenden GesundheitsfĂŒrsorge in den 1950er Jahren
Lindner U. Das Scheitern des klassischen Konzepts der vorbeugenden GesundheitsfĂŒrsorge in den 1950er Jahren. In: Schagen U, Schleiermacher S, eds. "Gesundheitsschutz fĂŒr alle" und die Ausgrenzung von Minderheiten. Berichte und Dokumente zur Zeitgeschichte der Medizin, 7. Berlin: Forschungsschwerpunkt Zeitgeschichte im Inst. fĂŒr Geschichte der Medizin; 2006: 100-110
Zwischen Tradition und Innovation - Ăffentliche Gesundheit, Sozialhygiene und Public Health
Ellerbrock D. Zwischen Tradition und Innovation - Ăffentliche Gesundheit, Sozialhygiene und Public Health. In: Schagen U, Schleiermacher S, eds. Sozialmedizin, Sozialhygiene und Public Health. Konzepte und Visionen zum VerhĂ€ltnis von Medizin und Gesellschaft in historischer Perspektive. Berichte und Dokumente zur Zeitgeschichte, 5. Berlin; 2002: 59-66
Die Charité und die Forschungspolitik der Kaiser-Wilhelm-Gesellschaft und der deutschen Forschungsgemeinschaft in der Zeit des Nationalsozialismus
Schmuhl H-W. Die Charité und die Forschungspolitik der Kaiser-Wilhelm-Gesellschaft und der deutschen Forschungsgemeinschaft in der Zeit des Nationalsozialismus. In: Schleiermacher S, Schagen U, eds. Die Charité im Dritten Reich. Zur Dienstbarkeit medizinischer Wissenschaft im Nationalsozialismus. Paderborn u.a.; 2008: 229-245
âImportance of Germany to Countries around and to World Economy makes it impossible to ignoreâ â The Rockefeller Foundation and Public Health in Germany after WWII
Ărztinnen - Patientinnen. Frauen im deutschen und britischen Gesundheitswesen des 20. Jahrhunderts
Lust und Unlust im Pfarrberuf. Eine Skizze zur Rolle des GefĂŒhls in der Pastoraltheologie
Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival.
This study investigated relationships between neuroblastomas (NBs) imaging phenotypes, tumor genomic profile and patient outcome.This IRB-approved retrospective observational study included 133 NB patients (73 M, 60 F; median age 15 months, range 0-151) treated in a single institution between 1998 and 2012. A consensus review of imaging (CT-scan, MRI) categorized tumors according to both the primarily involved compartment (i.e., neck, chest, abdomen or pelvis) and the sympathetic anatomical structure the tumors rose from (i.e., cervical, paravertebral or periarterial chains, or adrenal gland). Tumor shape, volume and image-defined surgical risk factors (IDRFs) at diagnosis were recorded. Genomic profiles were assessed using array-based comparative genomic hybridization and divided into three groups: "numerical-only chromosome alterations" (NCA), "segmental chromosome alterations" (SCA) and "MYCN amplification" (MNA). Statistical analyses included Kruskal-Wallis, Chi2 and Fisher's exact tests and the Kaplan-Meier method with log-rank tests and Cox model for univariate and multivariate survival analyses.A significant association between the sympathetic structure origin of tumors and genomic profiles was demonstrated. NBs arising from cervical sympathetic chains were all NCA. Paravertebral NBs were NCA or SCA in 75% and 25%, respectively and none were MNA. Periarterial NBs were NCA, SCA or MNA in 33%, 56% and 11%, respectively. Adrenal NBs were NCA, SCA or MNA in 16%, 36% and 48%, respectively. Among MNA NBs, 92% originated from the adrenal gland. The sympathetic anatomical classification was significantly better correlated to overall survival than the compartmental classification (P < .0003). The tumor volume of MNA NBs was significantly higher than NCA or SCA NBs (P < .0001). Patients with initial volume less than 160 mL had significantly better overall survival (P < .009). A "single mass" pattern was significantly more frequent in NCA NBs (P = .0003). The number of IDRFs was significantly higher in MNA NBs (P < .0001).Imaging phenotypes of neuroblastomas, including tumor origin along the sympathetic system, correlate with tumor genomic profile and patient outcome
Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival
A Medical Humanities Special Study Module on Principles of Medical Theory and Practice at the Charit??, Humboldt University, Berlin, Germany
- âŠ